Capital Analysts, LLC Becton Dickinson & CO Transaction History

Capital Analysts, LLC

$2.26 Billion
Q2 2024

A detailed history of Capital Analysts, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Capital Analysts, LLC holds 35,225 shares of BDX stock, worth $8.44 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

35,225

Previous 34,269 2.79%

Holding current value

$8.44 Million

Previous $8.48 Million 2.92%

% of portfolio

0.36%

Previous 0.4%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$225.07 - $246.17 $215,166 - $235,338	956 Added 2.79%	35,225 $8.23 Million
Q1 2024 May 14, 2024	BUY	$233.45 - $247.73 $383,791 - $407,268	1,644 Added 5.04%	34,269 $8.48 Million
Q4 2023 Jan 30, 2024	BUY	$232.24 - $267.23 $150,027 - $172,630	646 Added 2.02%	32,625 $7.96 Million
Q3 2023 Nov 13, 2023	BUY	$254.9 - $283.59 $536,309 - $596,673	2,104 Added 7.04%	31,979 $8.27 Million
Q2 2023 Aug 11, 2023	BUY	$238.39 - $265.32 $422,427 - $470,147	1,772 Added 6.31%	29,875 $7.89 Million
Q1 2023 May 05, 2023	BUY	$229.71 - $259.35 $169,066 - $190,881	736 Added 2.69%	28,103 $6.96 Million
Q4 2022 Feb 08, 2023	BUY	$218.29 - $256.91 $278,319 - $327,560	1,275 Added 4.89%	27,367 $6.96 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $88,639 - $458,967	1,737 Added 7.13%	26,092 $5.81 Million
Q2 2022 Aug 12, 2022	BUY	$234.74 - $275.42 $251,876 - $295,525	1,073 Added 4.61%	24,355 $6.01 Million
Q1 2022 May 12, 2022	BUY	$243.64 - $270.48 $267,029 - $296,446	1,096 Added 4.94%	23,282 $6.19 Million
Q4 2021 Feb 10, 2022	BUY	$230.08 - $250.94 $324,872 - $354,327	1,412 Added 6.8%	22,186 $5.58 Million
Q3 2021 Nov 04, 2021	BUY	$232.72 - $256.47 $215,033 - $236,978	924 Added 4.65%	20,774 $5.11 Million
Q2 2021 Nov 15, 2021	SELL	$232.65 - $254.58 $215,201 - $235,486	-925 Reduced 4.45%	19,850 $4.83 Million
Q2 2021 Aug 05, 2021	BUY	$232.65 - $254.58 $488,332 - $534,363	2,099 Added 11.24%	20,775 $5.05 Million
Q1 2021 May 17, 2021	BUY	$232.09 - $256.88 $362,292 - $400,989	1,561 Added 9.12%	18,676 $4.54 Million
Q4 2020 Feb 16, 2021	BUY	$221.92 - $245.94 $142,694 - $158,139	643 Added 3.9%	17,115 $4.28 Million
Q3 2020 Nov 12, 2020	SELL	$215.77 - $276.76 $23,950 - $30,720	-111 Reduced 0.67%	16,472 $3.83 Million
Q2 2020 Aug 07, 2020	SELL	$219.9 - $263.41 $155,249 - $185,967	-706 Reduced 4.08%	16,583 $3.97 Million
Q1 2020 May 08, 2020	BUY	$195.69 - $279.01 $76,319 - $108,813	390 Added 2.31%	17,289 $3.97 Million
Q4 2019 Feb 12, 2020	SELL	$236.45 - $266.82 $15,369 - $17,343	-65 Reduced 0.38%	16,899 $4.6 Million
Q3 2019 Nov 12, 2019	BUY	$230.58 - $256.08 $5,072 - $5,633	22 Added 0.13%	16,964 $4.29 Million
Q2 2019 Aug 13, 2019	SELL	$217.4 - $246.08 $185,659 - $210,152	-854 Reduced 4.8%	16,942 $4.27 Million
Q1 2019 May 13, 2019	SELL	$206.05 - $248.17 $75,414 - $90,830	-366 Reduced 2.02%	17,796 $4.44 Million
Q4 2018 Feb 13, 2019	SELL	$204.73 - $257.93 $3,070 - $3,868	-15 Reduced 0.08%	18,162 $4.09 Million
Q3 2018 Nov 07, 2018	BUY	$233.07 - $256.0 $54,538 - $59,904	234 Added 1.3%	18,177 $0
Q2 2018 Aug 03, 2018	SELL	$208.1 - $233.85 $3,329 - $3,741	-16 Reduced 0.09%	17,943 $0
Q1 2018 May 14, 2018	BUY	$205.46 - $240.27 $12,738 - $14,896	62 Added 0.35%	17,959 $3.89 Million
Q4 2017 Feb 14, 2018	BUY	$189.0 - $222.64 $3.33 Million - $3.92 Million	17,607 Added 6071.38%	17,897 $3.83 Million
Q4 2017 Feb 12, 2018	SELL	$189.0 - $222.64 $3.24 Million - $3.81 Million	-17,126 Reduced 98.33%	290 $65,000
Q3 2017 Nov 06, 2017	BUY	$186.89 - $198.9 $3.25 Million - $3.46 Million	17,416	17,416 $3.41 Million

Others Institutions Holding BDX

# of Institutions

1,733

Shares Held

252M

Call Options Held

586K

Put Options Held

649K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $68.4B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.

Account

Capital Analysts, LLC Becton Dickinson & CO Transaction History